Effect of some carcinogenic and non-carcinogenic polycyclic aromatic hydrocarbons on gap junction intercellular communication in hepatoma cell cultures

European Journal of Cell Biology

Volumn 85, Issue 5, 2006, Pages 387-397

  Sharovskaya, Julia ^a   Kobliakova, Ioulia ^a   Solomatina, Natalya ^b   Kobliakov, Valery ^b  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

Gap junction intercellular communication; Hepatoma cells; Polycyclic aromatic hydrocarbons

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ALPHA NAPHTHOFLAVONE; AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE; CYTOCHROME P450 1A1; LIGAND; MESSENGER RNA; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE;

ARTICLE; CARCINOGENICITY; CELL COMMUNICATION; CELL JUNCTION; CHEMICAL INTERACTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; HEPATOMA CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; LONG TERM EXPOSURE; METABOLISM; METABOLITE; PRIORITY JOURNAL;

EID: 33645936346     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcb.2005.11.006     Document Type: Article

References (56)

1. Barhoumi R., Mouneimne Y., Ramos K., Safe S., Phillips T., Centonze V., Ainley C., Gupta M., and Burghardt R. Analysis of benzo[a]pyrene partitioning and cellular homeostasis in a rat liver cell line. Toxicol. Sci. 53 (2000) 264-270
2. Blaha L., Kapplova P., Vondracek J., Upham B., and Machala M. Inhibition of gap-junctional intercellular communication by environmentally occurring polycyclic aromatic hydrocarbons. Toxicol. Sci. 65 (2002) 43-51
3. Blankenship A., and Matsumura F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced activation of a protein kinase, pp60src, in murine hepatic cytosol using a cell-free system. Mol. Pharmacol. 52 (1997) 667-675
4. Chramostova K., Vondracek J., Sindlerova L., Vojtesek B., Kozubik A., and Machala M. Polycyclic aromatic hydrocarbons modulate cell proliferation in rat hepatic epithelial stem-like WB-F344 cells. Toxicol. Appl. Pharmacol. 196 (2004) 136-148
5. Davis II J., Lauer F., Burdick A., Hudson L., and Burchiel S. Prevention of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-10A cell line. Cancer Res. 61 (2001) 3314-3320
6. Denison M., Pandin A., Nagy S., Baldwin E., and Bonati L. Ligand binding and activation of the Ah receptor. Chem. Biol. Interact. 141 (2002) 3-24
7. Fieser L., and Hershberg E. Synthesis of 3,4-benzopyrene derivatives. J. Am. Chem. Soc. 60 (1938) 1658-1664
8. Ge N., and Elferink C. A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. J. Biol. Chem. 273 (1998) 22708-22713
9. Gujaeva E., Ostashkina N., Kondalenko V., and Kobliakov V. Different pathways for mitogenic and enzyme induction signal transduction by cytochrome P450 inducers. Biochemistry (Moscow) 64 (1999) 929-933
10. Ide F., Suka N., Kitada M., Sakashita H., Kusama K., and Ishikawa T. Skin and salivary gland carcinogenicity of 7,12-dimethylbenz[a]anthracene is equivalent in the presence or absence of aryl hydrocarbon receptor. Cancer Lett. 214 (2004) 35-41
11. Jerina D., Chadha A., Cheh A., Schurdak M., Wood A., and Sayer J. Covalent bonding of bay-region diol epoxides to nucleic acids. Adv. Exp. Med. Biol. 283 (1991) 533-553
12. Jin D., Jung J., Lee Y., and Kim J. 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits cell proliferation through arylhydrocarbon receptor-mediated G1 arrest in SK-N-SH human neuronal cells. Neurosci. Lett. 363 (2004) 69-72
13. Kang K., Lee Y., Kim H., and Kim S. DI-(2-ethylhexyl) phthalate-induced cell proliferation is involved in the inhibition of gap junctional intercellular communication and blockage of apoptosis in mouse Sertoli cells. J. Toxicol. Environ. Health A 65 (2002) 447-459
14. Khesina A. Determination of benzo/a/pyrene in extracts by spectroluminescence. In: Egan H. (Ed). Environmental Carcinogens Selected Methods of Analysis. Analysis of Polycyclic Aromatic Hydrocarbons in Environmental Samples (1979), IARC Scientific Publications No. 3. International Agency for Research on Cancer, Lyon 215-229
15. Knight B., Yeoh G.C., Husk K.L., Ly T., Abraham L., Yu C., Rhim J., and Fausto N. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J. Exp. Med. 192 (2000) 1809-1818
16. Kobliakov V. Cytochrome P-450 in tumors and during carcinogenesis. Biokhimiia 60 (1995) 1747-1764
17. Kobliakov V. Inducers of the cytochrome P-450 superfamily as promoters of carcinogenesis. Biochemistry (Moscow) 63 (1998) 1043-1058
18. Krutovskikh V., and Yamasaki H. The role of gap junctional intercellular communications (GJIC) disorders in experimental and human carcinogenesis. Histol. Histopathol. 12 (1997) 761-768
19. Lowes K., Croager E., Olynyk J., Abraham L.J., and Yeoh G.C. Oval cell-mediated liver regeneration: role of cytokines and growth factors. J. Gastroenterol. Hepatol. 18 (2003) 4-12
20. Merchant M., Wang X., Kamps C., Rosengren R., Morrison V., and Safe S. Mechanism of benz[a]pyrene-induced Cyp 1a-1 gene expression in mouse Hepa 1c1c7 cells: role of the nuclear 6s and 4s proteins. Arch. Biochem. Biophys. 292 (1992) 250-257
21. Mesnil M., Piccoli C., and Yamasaki H. A tumor suppressor gene, Cx26, also mediates the bystander effect in HeLa cells. Cancer Res. 57 (1997) 2929-2932
22. Naruse M., Ishihara Y., Miyagawa-Tomita S., Koyama A., and Hagiwara H. 3-Methylcholanthrene, which binds to the arylhydrocarbon receptor, inhibits proliferation and differentiation of osteoblasts in vitro and ossification in vivo. Endocrinology 143 (2002) 3575-3581
23. Parrish A., Alejandro N., Bral C., Kevin K., Bowes R., and Ramos K. Characterization of glomerular cell phenotypes following repeated cycles of benzo[a]pyrene injury in vitro. Biochem. Pharmacol. 64 (2002) 31-39
24. Patten H., DeLong M., and Merrill Jr. A. Benzo(a)pyrene activates extracellular signal-related and p38 mitogen-activated protein kinases in HT29 colon adenocarcinoma cells: involvement in NAD(P)H:quinone reductase activity and cell proliferation. Toxicol. Appl. Pharmacol. 183 (2002) 160-167
25. Piechocki M., Burk R., and Ruch R. Regulation of connexin 32 and connexin 43 gene expression by DNA methylation in rat liver cells. Carcinogenesis 20 (1999) 401-406
26. Rakitsky V., Kobliakov V., and Turusov V. Nongenotoxic (epigenetic) carcinogens: pesticides as an example. A critical review. Teratogen. Carcinogen. Mutagen. 20 (2002) 229-240
27. Ramos K., and Parrish A. Growth-related signaling as a target of toxic insult in vascular smooth muscle cells: implications in atherogenesis. Life Sci. 57 (1995) 627-635
28. Ren P., Mehta P., and Ruch R. Inhibition of gap junctional intercellular communication by tumor promoters in connexin 43 and connexin 32 expressing liver cells. Carcinogenesis 19 (1998) 169-175
29. Rodriguez L., Dunsford H., Steinberg M., Chaloupka K., Zhu L., Safe S., Womack J., and Goldstein L. Carcinogenicity of benzo/a/pyrene and manufactured gas plant residues in infant mice. Carcinogenesis 18 (1997) 127-135
30. Ruch R., Porter S., Koffler L., Dwyer-Nield L., and Malkinson A. Defective junctional intercellular communications in lung cancer. Exp. Lung Res. 27 (2001) 231-243
31. Sai K., Kang K., Hirose A., Hasegawa R., Trosko J., and Inoue T. Inhibition of apoptosis by pentachlorophenol in v-myc-transfected rat liver epithelial cells: relation to down-regulation of gap junctional intercellular communication. Cancer Lett. 173 (2001) 163-174
32. Sanson M., Marcaud V., Robin E., Valery C., Sturtz F., and Zalc B. Connexin 43-mediated bystander effect in two rat glioma cell models. Cancer Gene Ther. 9 (2002) 149-155
33. Schrenk D., Karger A., Lipp H., and Bock K. 2,3,7,8-Tetrachloro-dibenzo-p-dioxin and ethinylestradiol as co-mitogen in cultured rat hepatocytes. Carcinogenesis 13 (1992) 453-456
34. Sharovskaja Y., Chailakhjan L., and Margolis L. Induction of intercellular communications in epithelial cell culture. Exp. Cell Res. 175 (1988) 404-408
35. Sharovskaja J., Vaiman A., Solomatina N., and Kobliakov V. Inhibition of gap junction intercellular communications in cell culture by polycyclic aromatic hydrocarbons (PAH) in the absence of PAH metabolism. Biochemistry (Moscow) 69 (2004) 413-419
36. Shvemberger I. A transplantable rat hepatoma strain G-27. Cytology 12 (1970) 1057-1059
37. Sigal S., Brill S., Fiorino A., and Reid L. The liver as a stem cell and lineage system. Am. J. Physiol. 263 (1992) G139-G148
38. Sogawa K., and Fuji-Kuriyama Y. Ah receptor, a novel ligand-activated transcriptional factor. J. Biochem. 122 (1997) 1075-1079
39. Solhaug A., Refsnes M., Lag M., Schwarze P., Husoy T., and Holme J. Polycyclic aromatic hydrocarbons induce both apoptotic and anti-apoptotic signals in Hepa1c1c7 cells. Carcinogenesis 25 (2004) 809-819
40. Stromskaya T., Rybalkina E., Stil A., Zabotina T., Filippova N., and Stavrovskaya A. Influence of exogenous RARα gene on MDR1 expression and P-glycoprotein function in human and rodent cell lines. Br. J. Cancer 77 (1998) 1718-1725
41. Tan Z., Chang X., Puga A., and Xia Y. Activation of mitogen-activated protein kinases (MAPKs) by aromatic hydrocarbons: role in the regulation of aryl hydrocarbon receptor (AHR) function. Biochem. Pharmacol. 64 (2002) 771-780
42. Tanaka T., Yamasaki H., and Mesnil M. Induction of a bystander effect in HeLa cells by using a bigenic vector carrying viral thymidine kinase and connexin32 genes. Mol. Carcinogen. 30 (2001) 176-180
43. Tannheimer S., Ethier S., Caldwell K., and Burchiel S. Benzo[a]pyrene- and TCDD-induced alterations in tyrosine phosphorylation and insulin-like growth factor signaling pathways in the MCF-10A human mammary epithelial cell line. Carcinogenesis 19 (1998) 1291-1297
44. Thilly W.G. Have environmental mutagens caused oncomutations in people?. Nat. Genet. 255-259 (2003)
45. Toyofuku T., Yabuki M., Otsu K., Kuzuya T., Hori M., and Tada M. Intercellular calcium signaling via gap junction in connexin-43-transfected cells. J. Biol. Chem. 273 (1998) 1519-1528
46. Trosko J.E. Is the concept of "tumor promotion" a useful paradigm?. Mol. Carcinogen. 30 (2001) 131-137
47. Trosko J.E., and Chang C. Stem cell theory of carcinogenesis. Toxicol. Lett. 49 (1989) 283-295
48. Trosko J.E., and Upham B. The emperor wears no clothes in the field of carcinogen risk assessment: ignored concepts in cancer risk assessment. Mutagenesis 20 (2005) 81-92
49. Upham B., Weis L., Rummel A., Masten S., and Trosko J. The effects of anthracene and methylated anthracenes on gap junctional intercellular communication in rat liver epithelial cells. Fundam. Appl. Toxicol. 34 (1996) 260-264
50. Upham B., Koski T., Rummel A., Wilson M., Horvath A., and Trosko J.E. Differential roles of 2, 6, and 8 carbon ceramides on the modulation of gap junctional communication and apoptosis during carcinogenesis. Cancer Lett. 191 (2003) 27-34
51. Warn-Cramer B., Cottrel G., Burt J., and Lau A. Regulation of connexin-43 gap junction intercellular communication by mitogen-activated protein kinase. J. Biol. Chem. 273 (1998) 9188-9196
52. Weis L., Rummel A., Masten S., Trosko J., and Upham B. Bay o baylike regions of PAH were potent inhibitors of gap junctional intercellular communication. Environ. Health Perspect. 106 (1998) 17-22
53. Wilson M., Close T., and Trosko J.E. Cell population dynamics (apoptosis, mitosis, and cell-cell communication) during disruption of homeostasis. Exp. Cell Res. 254 (2000) 257-268
54. Yamasaki H. Gap junction intercellular communications and carcinogenesis. Carcinogenesis 7 (1990) 1051-1058
55. Yano T., Hernandez-Blazquez F., Omori Y., and Yamasaki H. Reduction of malignant phenotype of HepG2 cell is associated with the expression of connexin 26 but not connexin 32. Carcinogenesis 22 (2001) 1593-1609
56. Zhang Y., Nakayama K., Nakayama K., and Morita I. A novel route for connexin 43 to inhibit cell proliferation: negative regulation of S-phase kinase-associated protein (Skp 2). Cancer Res. 63 (2003) 1623-1630